Login
← Go Back
Zydus Lifesciences
ZYDUSLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Pankaj R Patel · MD: Sharvil P Patel · Listing date: April 28, 2000 · Employees: 24412 · Ahmedabad · http://www.zyduscadila.com
Stock Price vs Company Growth
1d
0.3%
1w
1.4%
1m
4.4%
3m
19.9%
6m
12.8%
1y
47.4%
5y
31.3%
10y
12.6%
all
19.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 944 0.3%
933
1,159
Company Overview
Sales
21,484 Cr
Growth: 14.9%
Profit after Tax
4,303 Cr
Growth: 2.6%
Large Cap
95,014 Cr
P/E: 22.3x
Industry P/E: 36.0x
Fundamentals
Sales (Cr) ₹ 21,484
Growth 14.9%
EBITDA 28.9%
P/S 4.4x
Dividend 0.9%
P/E 22.3x
Book Value ₹ 220
PEG Ratio 1.5x
ROE 20.6%
P/B 4.3x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
3.63 %
Kotak Flexicap Fund
2.28 %
Government Pension Fund Global
1.15 %
Iepf
0.12 %
Llp
0.07 %
Promoters
Zydus Family Trust
74.86 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
Belongs to (37 Indices) view more
Investors (134)
pankaj.r...
marutham...
an.sujay
Followers (33)
deepak
nitin2
keerthi